186 related articles for article (PubMed ID: 37175698)
1. NAMPT and PARylation Are Involved in the Pathogenesis of Atopic Dermatitis.
Arroyo AB; Bernal-Carrión M; Cantón-Sandoval J; Cabas I; Corbalán-Vélez R; Martínez-Menchón T; Ferri B; Cayuela ML; García-Moreno D; Mulero V
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175698
[TBL] [Abstract][Full Text] [Related]
2. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.
Martínez-Morcillo FJ; Cantón-Sandoval J; Martínez-Navarro FJ; Cabas I; Martínez-Vicente I; Armistead J; Hatzold J; López-Muñoz A; Martínez-Menchón T; Corbalán-Vélez R; Lacal J; Hammerschmidt M; García-Borrón JC; García-Ayala A; Cayuela ML; Pérez-Oliva AB; García-Moreno D; Mulero V
PLoS Biol; 2021 Nov; 19(11):e3001455. PubMed ID: 34748530
[TBL] [Abstract][Full Text] [Related]
3. Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress.
Hegedűs C; Virág L
Redox Biol; 2014; 2():978-82. PubMed ID: 25460733
[TBL] [Abstract][Full Text] [Related]
4. Non-canonical roles of NAMPT and PARP in inflammation.
Martínez-Morcillo FJ; Cantón-Sandoval J; Martínez-Menchón T; Corbalán-Vélez R; Mesa-Del-Castillo P; Pérez-Oliva AB; García-Moreno D; Mulero V
Dev Comp Immunol; 2021 Feb; 115():103881. PubMed ID: 33038343
[TBL] [Abstract][Full Text] [Related]
5. Physiological levels of poly(ADP-ribose) during the cell cycle regulate HeLa cell proliferation.
Yamashita S; Tanaka M; Ida C; Kouyama K; Nakae S; Matsuki T; Tsuda M; Shirai T; Kamemura K; Nishi Y; Moss J; Miwa M
Exp Cell Res; 2022 Aug; 417(1):113163. PubMed ID: 35447104
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
7. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
8. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
9. Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents.
Li Y; Kong X; Chu X; Fu H; Feng X; Zhao C; Deng Y; Ge J
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930900
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
11. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
12. NAMPT/NAD
Dai Y; Lin J; Chen X; Ren J; Wu C; Shen H; Li X; Yu J; Jiang B; Yu L
Adv Biol (Weinh); 2024 May; 8(5):e2400028. PubMed ID: 38463014
[TBL] [Abstract][Full Text] [Related]
13. Mammalian N1-adenosine PARylation is a reversible DNA modification.
Musheev MU; Schomacher L; Basu A; Han D; Krebs L; Scholz C; Niehrs C
Nat Commun; 2022 Oct; 13(1):6138. PubMed ID: 36253381
[TBL] [Abstract][Full Text] [Related]
14. Cell Cycle Resolved Measurements of Poly(ADP-Ribose) Formation and DNA Damage Signaling by Quantitative Image-Based Cytometry.
Michelena J; Altmeyer M
Methods Mol Biol; 2017; 1608():57-68. PubMed ID: 28695503
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial PARP1 regulates NAD
Lee JH; Hussain M; Kim EW; Cheng SJ; Leung AKL; Fakouri NB; Croteau DL; Bohr VA
Exp Mol Med; 2022 Dec; 54(12):2135-2147. PubMed ID: 36473936
[TBL] [Abstract][Full Text] [Related]
16. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis.
Kiss B; Szántó M; Hegedűs C; Antal D; Szödényi A; Márton J; Méhes G; Virág L; Szegedi A; Bai P
Exp Dermatol; 2020 Jan; 29(1):79-85. PubMed ID: 31755591
[TBL] [Abstract][Full Text] [Related]
18. Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits.
Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Avitabile D; Albanesi C; Madonna S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202251
[TBL] [Abstract][Full Text] [Related]
19. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M
Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579
[TBL] [Abstract][Full Text] [Related]
20. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders.
Grimaldi G; Catara G; Palazzo L; Corteggio A; Valente C; Corda D
Biochem Pharmacol; 2019 Sep; 167():64-75. PubMed ID: 31102582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
